ロード中...
Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod
OBJECTIVE: Lymphopenia is a common occurrence of disease-modifying therapies (DMTs) for relapsing-remitting MS (RRMS). The aim of this study was to dissect the prevalence of various lymphocyte subsets in patients with RRMS treated with 2 DMTs commonly associated with lymphopenia, dimethyl fumarate (...
保存先:
| 出版年: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746425/ https://ncbi.nlm.nih.gov/pubmed/29296636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000432 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|